BioCentury
ARTICLE | Company News

Cellatope Corp, Cypress Bioscience deal

March 2, 2009 8:00 AM UTC

Cypress acquired Cellatope's cell-bound complement activation products (CB-CAP) technology for $2 million in cash and $3 million in milestones. Cypress will use the technology to develop a blood-based...